Guru Ownership Trend
Guru Analysis for Bio-Rad Laboratories, Inc. (BIO)
Bio-Rad Laboratories, Inc. (BIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.55 B.
Top institutional holders include First Eagle Investment and John Rogers.
Institutional sentiment is currently Bullish. This is evidenced by a $514,569.17 net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 384.4%. Conversely, Ken Fisher reduced exposure by 1.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Bio-Rad Laboratories, Inc. (BIO)
Major holders include First Eagle Investment ($765.21 M), John Rogers ($239.81 M), First Pacific Advisors ($117.99 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 4.35 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $514,569.17, with 5 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited BIO. The total reported sell value was $47.99 M.
Yes, 0 managers opened new positions in BIO, and 5 increased their existing holdings. The total reported buy value was $48.5 M.
